Infliximab Concentrations in Participants with Moderate to Severe COVID-19.
Overview
publication date
- November 30, 2023
published in
- Journal of clinical pharmacology Journal
Research
keywords
- Antirheumatic Agents
- COVID-19
Identity
Digital Object Identifier (DOI)
- 10.1002/jcph.2388
PubMed ID
- 38031826